Abstracts

Novel Post-Hospitalization Care Model Decreases Mortality in People With HIV in Zambia: Pilot Study

Background: Despite progress in HIV epidemic control in Zambia, HIV-related mortality remains high. Deaths are often preceded by hospitalization, and post-discharge mortality among people with HIV (PLWH) reaches 20-40% within six months due to individual, psychosocial, and systemic factors. We conducted a feasibility study of a community health worker (CHW)-led model to improve patient health…

The HIV Care Cascade in Medicaid, 2001-2015

Background: Medicaid serves as the largest single source of insurance for people with HIV (PWH) in the US, with approximately 40% of PWH covered by Medicaid. Not only does Medicaid represent a large, diverse population of PWH in US, it also represents some of the most vulnerable PWH, since eligibility is based on low income…

Reaching ECP Users With HIV and PEP Services in Kenyan Pharmacies

Background: Adolescent girls and young women (AGYW) seeking emergency contraceptive pills (ECP) to prevent conception also face increased risk of HIV acquisition due to implied unprotected sex. AGYW who are eligible for ECP are therefore likely to also be eligible for post-exposure prophylaxis (PEP) to reduce their risk of HIV acquisition. Pharmacies, where most AGYW…

Lymphogranuloma Venereum Among Men Who Have Sex With Men: 7 Versus 21 Days Doxycycline Effectiveness

Background: Current guidelines on treatment of symptomatic Lymphogranuloma venereum (LGV) caused by Chlamydia trachomatis (Ct) serovars L1-3 recommend 21 days of doxycycline (DOXY). Methods: Retrospective study on men who have sex with men (MSM) diagnosed with rectal or urethral Ct, treated with 7 or 21 days of DOXY between 2015-2022 at San Raffaele Scientific Institute,…

One-Dose HPV Vaccine Durability in a Moderate HIV Prevalence Setting: Mathematical Modeling Analyses

Background: The World Health Organization recommends a 1-dose human papillomavirus (HPV) vaccination strategy to increase coverage and accelerate cervical cancer elimination. However, the duration of efficacy of 1-dose is uncertain among women living with HIV (WLHIV); immune dysregulation may limit vaccine durability. We modelled the potential impact of a 1-dose HPV vaccination strategy on cervical…

Prevalence and Risk Factors Associated With HPV Infections Among Women with HIV Women in Meru, Kenya

Background: Cervical cancer, caused by, Human Papilloma Virus (HPV) is the leading cause of preventable deaths among women. High incidence and high mortality for cervical cancer are reported in low- and middle-income countries where immunocompromised HIV-infected women exhibit an increased risk. We determined circulating high-risk HPV genotypes in HIV-infected women in Meru, Kenya and identified…